Innovation Norway highlights Oncosyne’s journey from cancer research towards clinical application and the ecosystem supporting Norwegian healthtech innovation.
Oncosyne has been featured by Innovation Norway as part of its recent coverage of how incubators and innovation environments help Norwegian companies develop and grow.
The feature follows Oncosyne’s journey from its foundations in cancer research to the development of a regulatory-ready functional diagnostics platform that is now moving into clinical verification.
It also highlights the importance of the innovation ecosystem surrounding the company. Innovation Norway has supported Oncosyne through commercialisation funding, mentoring and international connections, while Oslo Cancer Cluster Incubator has provided access to infrastructure, expertise and a strong network within cancer research and innovation.
Together, these partnerships support Oncosyne’s ambition to translate functional diagnostics into more precise treatment decisions for cancer patients and contribute to building internationally competitive healthtech from Norway.
Read the full story on Innovation Norway → https://www.innovasjonnorge.no/kundehistorie/oncosyne